Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07386184Not ApplicableNot Yet Recruiting

Collagenic vs Collagen-enriched Graft in Sinus Elevation: RCT

Role: lead

NCT07156110Not ApplicableRecruiting

Prosthetic Modality and MBL

Role: lead

NCT07041411Not ApplicableCompleted

Transcrestal Sinus Lift With OSSIX Bone vs BIOSS Collagen

Role: lead

NCT05500911Not ApplicableCompleted

Bioactive Surfaces vs. Conventional Surfaces in Implants Placed in Atrophic Maxilla With Simultaneous Sinus Lift

Role: lead

NCT06412705Not ApplicableCompleted

Vit D and Post-extractive Bone Turnover

Role: lead

NCT05821673Not ApplicableCompleted

Soft Tissue Integration of Different Abutment Surfaces

Role: lead

NCT04381455Completed

Evaluation of OSSIX® Bone in Sinus Elevation

Role: lead

All 7 trials loaded